# Bcl-XL_42-CAF09b Vaccination for Patients With Prostate Cancer With Lymph Node Metastases

> **NCT03412786** · PHASE1 · COMPLETED · sponsor: **Herlev Hospital** · enrollment: 20 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** Bcl-Xl_42-CAF09b vaccine

## Key facts

- **NCT ID:** NCT03412786
- **Lead sponsor:** Herlev Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-01
- **Primary completion:** 2021-12-08
- **Final completion:** 2021-12-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03412786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03412786, "Bcl-XL_42-CAF09b Vaccination for Patients With Prostate Cancer With Lymph Node Metastases". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03412786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*